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Abstract
Though some research has begun to examine specific factors related to race that should be targeted
in the design of interventions to improve medication adherence, there remains an underreporting of
factors that contribute to the use of hypertensive medications by race.
Methods—This study examined medication use reported by a sample of elderly, controlled and
uncontrolled hypertensive patients from the North Carolina Established Populations for the
Epidemiologic Studies of the Elderly (NC EPESE) study.
Results—In the adjusted final multivariable models of medication use over time, in both Caucasian
and African-American women, those with higher BMI were more likely to report taking their
medication over time; satisfaction with their medical care was predictive among Caucasian women
and receiving treatment from a minority physician was predictive among African-American women.
Conclusion—Focusing on individual-level characteristics and the different issues that may
underlie specific ethnic groups, particularly health care provider characteristics, may help to develop
more precisely targeted interventions to improve a full range of healthcare services that are often
needed by elderly hypertensive patients.
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Research has thoroughly identified racial and ethnic disparities in hypertension and
cardiovascular health problems in the U.S. among African Americans and Caucasians.1–3
Research has concluded that the prevalence of hypertension among African Americans is
among the highest in the United States.4–6 Research has also shown that African Americans
experience the onset of hypertension at a younger age and with worse disease severity.4,7
Ferdinand and Armani (2007) conclude that a series of genetic and environmental factors
contribute to the high prevalence of hypertension in the African American population.
In addition, Bosworth and colleagues (2006) looked at factors that may explain racial
differences in blood pressure control. The authors found that African Americans were more
likely to be nonadherent to medication regimens, functionally illiterate, and have a hypertensive
family member than their Caucasian counterparts.8 Bosworth and colleagues (2006) concluded
that African Americans were more likely to have lower levels of blood pressure control
compared to Caucasians, even after controlling for 20 possible explanatory factors. In a more
recent study, Bosworth and colleagues (2008) again explored health disparities in blood
pressure control. They concluded that age, medication nonadherence, and worrying about
blood pressure status contributed to the racial disparity of blood pressure control status.9 Giles
and colleagues (2007) similarly found that treated African Americans and Mexican Americans
had the lowest rates of treated blood pressure control.10 But, this study, like many others,
recommends that interventions for improving medication adherence should take race into
account. Though the importance of race to intervention design has been identified across
several studies, only a minority of studies have taken the next step to identify specific providers
and/or patient characteristics to improve racial awareness in practice.
For example, Kressin and colleagues (2007) looked at race, health beliefs, process of care, and
medication adherence in a sample of hypertensive patients. Their research did not find a
significant association between race and medication adherence. But, they did find that the
providers of African American patients were significantly more active in educating their
patients about medication adherence. The authors concluded that racial disparities may be
reduced if patients and their providers take hypertension seriously by more actively advising
and counseling hypertensive patients about medication use and disease states.11 Rose and
colleagues (2000) conducted a qualitative study that explored the contexts of adherence for
African American males with high blood pressure. Their qualitative findings suggested that
adherence fluctuated depending on social, economic, and personal circumstances, in addition
to the empathetic assistance from providers.12 Viswanathan and Lambert (2005) identified
several factors that positively affected African-Americans medication adherence as well as
factors that negatively impacted consistent use.13 Specifically, reminders of medication
effectiveness, lifesaving attributed and a reminder of regimens were found to positively impact
medication use. In contrast, factors such as fear of side effects, fear of dependency, and the
hassle of taking regularly prescribed medications were among the factors that contributed to
African-Americans resistance to consistent medication use.13
Though some research has begun to examine specific factors related to race that should be
targeted in the design of interventions to improve medication adherence, there remains an
underreporting of factors that contribute to the use of hypertensive medications by race,
particularly service level factors. This paper intends to further analyze the association between
current medication use and several other covariates, including service level factors, with
particular attention to race among the EPESE participants with controlled and uncontrolled
hypertension.
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This observational, longitudinal study is based on a subsample of hypertensive participants
from the North Carolina Established Populations for the Epidemiologic Studies of the Elderly
(NC EPESE). The purpose of EPESE was to longitudinally evaluate risk factors for diseases,
disabilities, hospitalizations, institutionalization, and mortality among the elderly in four U.S.
regions (East Boston, MA; two rural counties in Iowa; New Haven, CT; and portions of five
counties in the north-central region of NC). These data were collected from residents from five
urban and rural counties in the Piedmont Region of North Carolina. Data collection efforts
employed a four-stage, stratified, probability sample with an oversample of African-
Americans. Data were collected through in-person household interviews conducted every three
years. The EPESE study design included continued follow-up on morbidity and mortality in
addition to nursing home and hospital admissions. Approximately 62 percent of the participants
across all four waves were lost to death, refusal, or follow-up14. Further explanation of the
rationale and survey design is published elsewhere.15
For the NC EPESE dataset, data were collected over four waves: Wave 1 (baseline, 1987);
Wave 2 (1990); Wave 3 (1994); and Wave 4 (1998). African Americans were oversampled for
more meaningful racial comparisons. Wave 1 included 4136 participants (2263 African
American and 1873 Caucasians), aged 65–75 years. For the present study, participants were
followed over the subsequent waves after being classified as having controlled or uncontrolled
hypertension.
Study Sample
The study sample included all hypertensive participants who self-reported being told by a
physician that they had high blood pressure and yielded high blood pressure measurements in
at least one wave. The study sample included 1,248 African Americans participants and 1,665
Caucasian participants from Wave 1.
Measures
Outcome variable—The outcome was derived from the following item: “Are you currently
taking any medication for [high blood pressure]?” For the purposes of this analysis, the
outcome variable looks at changes in hypertensive medication use over the course of four time
periods.
Demographics/Background—Demographic and behavioral information such as income,
education level, and living arrangements were collected from the participants at each wave.
Gender, age, years of education, marital status (married: yes/no), employment status (currently
working: yes/no), annual household income (<$15,000), and living in a rural area (yes/no) were
collected from the participants at each wave.
Health characteristics—Various elements of the participants’ health profile that were
collected included smoking behavior according to the following question:
• “Do you smoke cigarettes regularly now?”
The participant’s height and weight were taken at each visit, and the standard formula kg/m2
was used to calculate body mass index. This analysis employs the mean body mass index.
Controlled blood pressure status was defined according to the following two criteria: 1) being
told by a physician that he/she was hypertensive; yet, 2) having a normal or prehypertensive
blood pressure measurements (< 140 mm = systolic and <90 mm = diastolic) at the time of
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data collection. Uncontrolled blood pressure status was defined as having blood pressure
measurements (≥ 140 mm = systolic or ≥ 90 mm = diastolic) at the time of data collection.
Health services—Previous health services history was assessed using participants’
responses to the following questions:
• “Have you been in a nursing home in the past 12 months;”
• “Have you put off going to the doctor when necessary;”
• “Are you satisfied with the medical care received;” and
• “Did you receive medical care in a public facility.”
Health services variables were dichotomized (yes/no) for these analyses.
Health care provider characteristics—This domain included: physician race (minority:
African-American/Non-Hispanic, American Indian/Alaskan Native, Asian/Pacific Islander,
Hispanic and other; versus Caucasian/Non-Hispanic), physician gender, age, years since
medical school graduation, and general/family specialty. Years since medical school
graduation was calculated by subtracting the physician’s graduation year from the year of the
wave. This information was linked to EPESE from the North Carolina Health Professions Data
System (HPDS) which collects and disseminates timely data on licensed health care
professionals16.
Analyses
Analyses for this study sought to investigate the relationship between current medication use
and several domains of covariates for elderly African Americans and for Caucasians who either
had controlled or uncontrolled hypertension. The decision to look separately at the two racial
groups was based on an initial multivariable model that estimated the effects for all of the
variables included in the demographics domain. In addition to other variables, race was a
significant predictor of current medication use (OR=1.35; p=0.002) over time. Therefore, the
analyses examine the significant predictors of medication use according to race.
This analysis employed generalized estimating equations (GEE) to simultaneously test for
trends across time for each of the demographic, health characteristics, health services, and
healthcare provider characteristic domains according to each racial group using a logistic link
function in the GEE analysis. The GEE models allow for assessment of impacts of the primary
predictor variables and multiple covariates on the outcome variable.17 The GEE analysis first
looked at the bivariate association of each independent variable with the outcome variable.
These results are presented in the first column of table 3 and table 4. Then, the analysis included
the variables in each domain in an individual model and these results are presented in the second
column. Finally, the final multivariable model included any variables that resulted in significant
odds ratios across each of the domain models. These results are presented in the third column
of table 3 and table 4. Variable reduction was accomplished by including covariates with a p-
value less than 0.10 in the domain models in the final multivariable model. Odds ratios
produced by this technique estimate the odds of a predicted outcome (e.g., current medication
use) associated with exposure to independent variables (e.g., gender, age). All analyses were
generated using Version 9.1.3 of SAS®.
Results
Descriptive Analyses
Table 1 describes the number of individuals who fall into each category of hypertension status
by wave. According to Table 1, at wave 1, most participants fall into the uncontrolled
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hypertension category (n=2,135; 73.3%). Each wave follows a similar pattern of frequency
with the most participants falling into the uncontrolled hypertension category. Also, over half
of the sample reported currently taking medications at Wave 1 (n=1,619; 55.6%). As a result
of these frequencies, an additional sub-analysis was completed to examine the potential for
bias between hypertension status and medication use. Based on the findings of this sub-
analysis, there was no evidence of a bias.
Table 2 presents the overall sample characteristics by race and wave for all of the independent
variables. Only the wave 1 sample will be discussed here. The sample was almost equally one-
third male for African-Americans and Caucasians. The mean age for African-Americans was
73 years old (SD=6.6) and 74 years old for Caucasians (SD=6.4). Overall, a higher percentage
of the African-American sample live in a rural area compared to Caucasians. Finally, a
comparable percentage of Caucasian and African-American participants had a “controlled”
level of hypertension.
According to the Health Services domain, a slightly higher percentage of Caucasians resided
in a nursing home in the past 12 months compared to the African-American sample. A much
higher number of African-American participants report receiving care in a public facility when
compared to Caucasian participants. When looking at health care provider characteristics, there
was a much higher number of minority physicians treating the African-American sample than
for the Caucasian sample. The mean age of the healthcare providers for the African-American
and Caucasian sample were similar comparable.
GEE Models with Logistic Link
Bivariate Analysis – Caucasian Sample—In Table 3 and Table 4, the first column
displays bivariate associations with current medication use for Caucasians and African-
Americans, respectively, for the four domains of interest. Tests of the statistical significance
of each bivariate association were conducted with logistic regression. A number of variables
in each domain were found to be associated individually with current medication use in each
racial group.
In Table 3, there were several significant odds ratios found in the bivariate associations with
current medication use for the Caucasian sample. First, in the demographics domain, women
were more likely to be taking their medication compared to men (OR=1.35; 95% CI=1.05,
1.72). For every one year increase in years of education, the odds of a participant taking their
medication increases by four percent (OR=1.04; 95% CI=1.01, 1.07). In the health
characteristic domain, body mass index was significantly associated with medication use. For
a one unit increase in body mass index, the odds a participant is taking their medication
increases by three percent (OR=1.03; 95% CI=1.00, 1.06) over time. In the health services
domain, those who reported being concurrently satisfied with the medical care received
(OR=1.44; 95% CI=1.03, 2.00) were also more likely to report taking their medication than
those who were not satisfied over time. Further, participants who did not receive care in a
public facility were more likely to take their medication (OR=1.45; 95% CI=1.04, 2.04) over
time. Annual household income (<$15,000) (OR=0.80; 95% CI=0.63, 1.03), residing in a
nursing home in the past 12 months (OR=0.73; 95% CI=0.52, 1.04) and put off going to the
doctor when necessary (OR=0.74, 95% CI=0.55, 1.00) were nearly significant predictors of
medication use over time.
Multivariable Domain Models – Caucasian Sample—In the demographics domain,
being male (OR=0.67, 95% CI=0.49, 0.92), was the only significant predictor of medication
use over time. In the health characteristics domain, body mass index (OR=1.03; 95% CI=1.00,
1.06) was the only covariate significantly associated with medication use over time. According
to the health services domain, participants who reported being satisfied with the medical care
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they received (OR=1.36; 95% CI=0.96, 1.92) and participants who received care in a public
facility (OR=0.72; 95% CI=0.50, 1.03) were nearly significant predictors of medication use
over time. No variables in the health care provider characteristics domain were significantly
associated with the outcome.
Multivariable Final Models – Caucasian Sample—Variables selected in each domain
at p<0.10 were included in a final model predicting medication use for Caucasians. The
following covariates were significantly associated with the participants using their medication
in the final multivariable model: male (OR=0.69; 95% CI=0.52, 0.91), body mass index
(OR=1.03; 95% CI=1.00, 1.06), and satisfied with medical care received (OR=1.44; 95%
CI=1.01, 2.06). Receiving care in a public facility (OR=0.72; 95% CI=0.50, 1.05) was an
additional predictor in the final model that was nearly significant. There were no significant
predictors from the health care provider characteristics domain included in the final model.
Bivariate Analysis – African-American Sample—Table 4 presents the bivariate
associations with medication use over time for the African-American sample. There were
several significant bivariate associations in the four domains. First, in the demographics
domain, women were more likely to report using their medications (OR=1.72; 95% CI=1.37,
2.13) over time. For every one year increase in education, the odds a participant is taking their
medication increases by four percent (OR=1.04; 95% CI=1.02, 1.07) over time. Married
participants were also more likely to report using their medication (OR=1.26; 95% CI=1.01,
1.59) and participants whose income was $15,000 or more were more likely to be taking their
medication (OR=1.45; 95% CI=1.02, 2.04). Participants who resided in a rural area were also
more likely to report medication use over time (OR=1.39; 95% CI=1.13, 1.71). In the health
characteristic domain, a one unit increase in body mass index was significantly associated with
a five percent increase in the odds a participant is taking their medication (OR=1.05; 95%
CI=1.03, 1.07). Further, participants with controlled blood pressure were more likely to be
taking their medication compared to those with uncontrolled blood pressure (OR=1.23; 95%
CI=1.03, 1.45) over time. In the health services domain, participants who did not put off going
to the doctor when necessary were more likely to report taking their medication than those who
did not (OR=1.35; 95% CI=1.02, 1.79). Also, participants who did not receive care in a public
facility were more likely to report using their medication (OR=1.39; 95%CI=1.15, 1.69).
Residing in a nursing home in the past 12 months (OR=1.72; 95%CI=0.99, 2.98) was a nearly
significant predictor of medication use over time. In the health care provider characteristics
domain, minority racial status for the physician (OR=1.25; 95%CI=1.00, 1.55) was a nearly
significant predictor of medication use over time.
Multivariable Domain Models – African-American Sample—In the demographics
domain, male gender (OR=0.47, 95% CI=0.36, 0.63), years of education (OR=1.05, 95%
CI=1.02, 1.09), being married (OR=1.65, 95% CI=1.23, 2.22) and residing in a rural area
(OR=1.43, 95% CI=1.13, 1.81) were significantly associated with medication use over time.
In the health characteristics domain, body mass index (OR=1.05; 95% CI=1.03, 1.07) and
controlled blood pressure (OR=1.31, 95% CI=1.08, 1.59) were significantly associated with
medication use over time. According to the health services domain, participants who received
care in a public facility (OR=0.73, 95% CI=0.60, 0.89) was significantly associated with
medication use over time. Further, putting off going to the doctor when necessary (OR=0.75,
95% CI=0.55, 1.01) was a nearly significant predictor of medication use over time. According
to the health care provider characteristics, minority racial status for the physician (OR=1.25,
95% CI=0.99, 1.57) was a nearly significant predictor of using medication over time.
Multivariable Final Models – African-American Sample—Variables selected in each
domain at p<0.10 were included in a final model predicting current medication use in the
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African-American sample. The final model resulted in the following variables as significantly
associated with medication use over time: male (OR=0.52; 95% CI=0.37, 0.74), body mass
index (OR=1.05; 95% CI=1.02, 1.08), and minority physician (OR=1.36; 95% CI=1.03, 1.80).
Being married (OR=1.36; 95% CI=0.96, 1.91), living in a rural area (OR=1.31; 95% CI=0.96,
1.79), and controlled blood pressure (OR=1.26; 95% CI=0.97, 1.65) were additional covariates
that were nearly significant in the final model.
Discussion
This study examined current medication use in an elderly sample of hypertensive patients. An
initial multivariable model of the variables included in the demographics domain yielded a
significant association between race and current medication use. This finding suggests the
importance of examining factors that contribute to medication use within the specific context
of race. Therefore, two, separate multivariable models were tested for Caucasians and African-
Americans.
For the entire sample (n=2,913), 50.7 percent of the Caucasian participants reported currently
taking medication at Wave 1 compared to a higher 59.2 percent of the African-American
participants. Furthermore, the majority of the total sample was female, single, and unemployed.
Less than one-half of the Caucasian sample reported living in a rural area but in contrast to
over half of the African-American sample who reported living in a rural area. In the adjusted
final multivariable models of medication use over time, in both Caucasian and African-
American women, those with higher BMI were more likely to report taking their medication
over time; satisfaction with their medical care was predictive among Caucasian women and
receiving treatment from a minority physician was predictive among African-American
women. Though direct comparisons should not be drawn between the two multivariable
models, contrasting the two racial groups yields noteworthy differences.
Specifically, in the bivariate analysis, gender, years of education, body mass index and having
received care in a public facility were significant predictors of medication use over time in
both the Caucasian and African-American sample. Satisfaction with medical care received was
predictive of medication use over time for Caucasians but not African-Americans. Being
married, annual household income, living in a rural area, controlled blood pressure status, and
minority race of the physician were predictive or nearly predictive of medication use over time
in the African-American sample, but not in the Caucasian sample. These differences suggest
that specific demographic, health characteristics, and health provider characteristics may be
important predictors of current medication use over time for African-Americans and should
be further investigated.
Research has shown that the characteristics of providers can play a significant role in patient
behaviors for African-Americans,11,17 particularly treatment adherence. For example, when
a physician is a minority, the African-American participant is more likely to report medication
use over time (OR=1.36; 95% CI=1.03, 1.80) controlling for other covariates. But, as Rose
and colleagues (2000) suggest, it is important to consider the social, economic, and personal
circumstances surrounding an African-American hypertensive patient, in addition to the health
care provider characteristics.
Study limitations
This study includes several limitations. First, the data relied on self-report to gather sensitive
health information on the participants' personal health history; therefore, the validity and
reliability of the self-report data should be considered in this study. Specifically,
underreporting, unassociated with any covariates, may bias the findings present here which
therefore, indicate that the applicability of the findings to the larger populations should be
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interpreted cautiously. Further, this sample consists of individuals recruited from health
treatment settings. Therefore, these data do not speak to current medication use for those
hypertensive patients who are not engaged in consistent health treatment.
Conclusion
Decades of research have shown that hypertensive patients have a wide range of healthcare
needs and depend greatly on the use of effective medication regimens. But consistent
medication use poses a consistent challenge for providers and the overall health care system.
Similarly, disparities in health consistently pose challenges for providers, policymakers, and
researchers alike. Yet little research has systematically explored different aspects of disparities
as they relate to different kinds of health problems. This analysis identified specific correlates
to current medication use among Caucasians and African-Americans, separately.
The findings suggest that medication use is a concern for Caucasian males who have a lower
body mass index and were not satisfied with the medical care they have received. Furthermore,
medication use may also be more of a concern for African-American males who have a lower
body mass index and Caucasian physicians. In sum, focusing on individual-level characteristics
and the different issues that may underlie specific ethnic groups may help to develop more
precisely targeted interventions to improve a full range of healthcare services that are often
needed by elderly hypertensive patients.
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Table 1
Frequencies for hypertension categories by wave
Wave 1 Wave 2 Wave 3 Wave 4
N=2,913 N=2,855 N=2,432 N=1,470
n (%) n (%) n (%) n (%)
Hypertension Status
  Controlled 778(26.7) 1,035(36.3) 826(34.0) 610(41.5)
  Uncontrolled 2,135(73.3) 1,513(53.0) 1,234(50.7) 781(53.1)
  Currently using prescribed
  hypertensive medications
1,619(55.6) 1,446(50.6) 1,097(45.1) 529(36.0)
  Not currently taking meds 363(12.5) 393(13.8) 312(12.8) 66(4.5)

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































J Natl Med Assoc. Author manuscript; available in PMC 2009 December 28.
